Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-001659
Filing Date
2009-01-22
Accepted
2009-01-22 13:27:32
Documents
1
Period of Report
2008-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3995
  Complete submission text file 0001140361-09-001659.txt   5921
Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104
Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WEXFORD CAPITAL LLC 411 WEST PUTNAM AVE, SUITE 125 GREENWICH CT 06830
Business Address 203-862-7051
Mieyal Paul A (Reporting) CIK: 0001412471 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 09538742